DE122007000051I2 - Kristallmodifikation von 1-(2,6-difluorbenzyl) -1h-1,2,3-triazol-4-carbonsäureamid und seine verwendung als antiepileptikum - Google Patents

Kristallmodifikation von 1-(2,6-difluorbenzyl) -1h-1,2,3-triazol-4-carbonsäureamid und seine verwendung als antiepileptikum

Info

Publication number
DE122007000051I2
DE122007000051I2 DE122007000051C DE122007000051C DE122007000051I2 DE 122007000051 I2 DE122007000051 I2 DE 122007000051I2 DE 122007000051 C DE122007000051 C DE 122007000051C DE 122007000051 C DE122007000051 C DE 122007000051C DE 122007000051 I2 DE122007000051 I2 DE 122007000051I2
Authority
DE
Germany
Prior art keywords
antiepilepticum
difluorbenzyl
triazol
carboxyl acid
crystal modification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE122007000051C
Other languages
English (en)
Other versions
DE122007000051I1 (de
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4209650&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE122007000051(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis AG filed Critical Novartis AG
Publication of DE122007000051I1 publication Critical patent/DE122007000051I1/de
Publication of DE122007000051I2 publication Critical patent/DE122007000051I2/de
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
DE122007000051C 1997-06-10 1998-06-08 Kristallmodifikation von 1-(2,6-difluorbenzyl) -1h-1,2,3-triazol-4-carbonsäureamid und seine verwendung als antiepileptikum Active DE122007000051I2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH140497 1997-06-10
PCT/EP1998/003427 WO1998056772A1 (en) 1997-06-10 1998-06-08 Crystal modification of 1-(2,6-difluorobenzyl)-1h-1,2,3--triazole-4-carboxamide and its use as antiepileptic

Publications (2)

Publication Number Publication Date
DE122007000051I1 DE122007000051I1 (de) 2007-11-08
DE122007000051I2 true DE122007000051I2 (de) 2009-02-19

Family

ID=4209650

Family Applications (3)

Application Number Title Priority Date Filing Date
DE69811500T Expired - Lifetime DE69811500T2 (de) 1997-06-10 1998-06-08 Kristallmodifikation von 1-(2,6-difluorbenzyl)-1h-1,2,3-triazol-4-carbonsäureamid und seine verwendung als antiepileptikum
DE69813560T Expired - Lifetime DE69813560T2 (de) 1997-06-10 1998-06-08 Kristallmodifikation von 1-(2,6-difluorbenzyl)-1h-1,2,3-triazol-4-carbonsäureamid und seine verwendung als antiepileptikum
DE122007000051C Active DE122007000051I2 (de) 1997-06-10 1998-06-08 Kristallmodifikation von 1-(2,6-difluorbenzyl) -1h-1,2,3-triazol-4-carbonsäureamid und seine verwendung als antiepileptikum

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DE69811500T Expired - Lifetime DE69811500T2 (de) 1997-06-10 1998-06-08 Kristallmodifikation von 1-(2,6-difluorbenzyl)-1h-1,2,3-triazol-4-carbonsäureamid und seine verwendung als antiepileptikum
DE69813560T Expired - Lifetime DE69813560T2 (de) 1997-06-10 1998-06-08 Kristallmodifikation von 1-(2,6-difluorbenzyl)-1h-1,2,3-triazol-4-carbonsäureamid und seine verwendung als antiepileptikum

Country Status (37)

Country Link
US (6) US6740669B1 (de)
EP (2) EP0994863B1 (de)
JP (2) JP3672575B2 (de)
KR (2) KR100409168B1 (de)
CN (3) CN1298708C (de)
AR (4) AR012945A1 (de)
AT (2) ATE232852T1 (de)
AU (2) AU725517B2 (de)
BR (2) BR9804946A (de)
CA (3) CA2614926C (de)
CO (2) CO4940448A1 (de)
CY (1) CY2007014I2 (de)
CZ (2) CZ292481B6 (de)
DE (3) DE69811500T2 (de)
DK (2) DK0994863T3 (de)
ES (2) ES2192779T3 (de)
FR (1) FR07C0037I2 (de)
HK (3) HK1028241A1 (de)
HU (2) HU225153B1 (de)
ID (2) ID21014A (de)
IL (2) IL125733A (de)
LU (1) LU91345I2 (de)
MY (2) MY120156A (de)
NL (1) NL300284I2 (de)
NO (2) NO329314B1 (de)
NZ (2) NZ331370A (de)
PE (2) PE79799A1 (de)
PL (2) PL191943B1 (de)
PT (1) PT994864E (de)
RU (2) RU2198167C2 (de)
SI (2) SI0994863T1 (de)
SK (2) SK283734B6 (de)
TR (2) TR199801631T1 (de)
TW (2) TW526195B (de)
UY (1) UY25844A1 (de)
WO (2) WO1998056773A1 (de)
ZA (2) ZA984967B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW526195B (en) 1997-06-10 2003-04-01 Novartis Ag Crystal modifications of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide and their use
TW200404802A (en) * 2002-05-31 2004-04-01 Schering Corp Xanthine phosphodiesterase V inhibitor polymorphs
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds
US7875284B2 (en) * 2006-03-10 2011-01-25 Cook Incorporated Methods of manufacturing and modifying taxane coatings for implantable medical devices
US20090069390A1 (en) * 2007-09-12 2009-03-12 Protia, Llc Deuterium-enriched rufinamide
CA2736703A1 (en) 2008-10-13 2010-04-22 Cipla Limited Process for the preparation of rufinamide
CN101768124B (zh) * 2008-12-30 2012-01-04 北京本草天源药物研究院 一种药物晶体及其制备方法和用途
IT1395736B1 (it) * 2009-08-04 2012-10-19 Dipharma Francis Srl Forme cristalline di rufinamide
RU2594155C2 (ru) * 2009-09-04 2016-08-10 Тэктикал Терапеутикс, Инк Новые композиции и способы получения 5-амино- или замещенных амино-1,2,3-триазолов и триазол-оротатных композиций
US8884026B2 (en) 2010-04-30 2014-11-11 Laboratorios Lesvi, S.L. Process for preparing rufinamide intermediate
EP2465853A1 (de) * 2010-12-14 2012-06-20 Laboratorios Lesvi, S.L. Polymorph von Rufinamid und Verfahren zu seiner Herstellung
ITMI20110718A1 (it) * 2011-04-29 2012-10-30 Dipharma Francis Srl Procedimento per la purificazione di rufinamide
WO2014013511A2 (en) * 2012-07-20 2014-01-23 Hetero Research Foundation Rufinamide solid dispersion
WO2021099481A1 (en) 2019-11-20 2021-05-27 Medichem, S.A. Solid composition containing rufinamide

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992378A (en) 1973-12-26 1976-11-16 Eli Lilly And Company Fluoralkyl quinoxadinediones
US4156734A (en) * 1976-02-13 1979-05-29 Merck & Co., Inc. Antihypertensive compositions containing an aryl-substituted alanine azo and an arylhydrazino-propionic acid
GB1511195A (en) 1976-10-18 1978-05-17 Ici America Inc Triazole derivatives
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US4346097A (en) * 1980-09-30 1982-08-24 Warner-Lambert Company Method for treating convulsions with pyrazole-4-carboxamide derivatives
FI834666A (fi) 1982-12-23 1984-06-24 Ciba Geigy Ag Foerfarande foer framstaellning av nya aralkyltriazolfoereningar.
US4789680A (en) * 1982-12-23 1988-12-06 Ciba-Geigy Corporation Aralkyltriazole compounds
US4511572A (en) * 1983-03-18 1985-04-16 The University Of Kentucky Research Foundation Triazoline anticonvulsant drugs
PH22568A (en) 1985-04-18 1988-10-17 Ciba Geigy Ag Fluorinated benzyl triazoles and pharmaceutical compositions containing the same
CA2002864C (en) 1988-11-29 1999-11-16 Eddy J. E. Freyne (1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives
JPH02214504A (ja) 1989-02-15 1990-08-27 Nissan Chem Ind Ltd 光学活性キノキサリン化合物の晶析法
EP0484437A4 (en) 1989-07-27 1994-06-01 Searle & Co Renal-selective prodrugs for the treatment of hypertension
IL96507A0 (en) 1989-12-08 1991-08-16 Merck & Co Inc Nitrogen-containing spirocycles and pharmaceutical compositions containing them
EP0556393B1 (de) 1990-11-06 2000-07-26 Yamanouchi Pharmaceutical Co. Ltd. Kondensiertes pyrazinderivat
JP2753911B2 (ja) 1991-12-06 1998-05-20 キッセイ薬品工業株式会社 Ｎ−ｔｅｒｔ−ブチル−１−メチル−３，３−ジフェニルプロピルアミン塩酸塩の結晶多形およびその製造方法
DE4217952A1 (de) 1992-05-30 1993-12-02 Basf Ag Chinoxalin-2,3(1H,4H)-dione
US5248699A (en) * 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
US5631373A (en) 1993-11-05 1997-05-20 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones
GB9418443D0 (en) 1994-09-13 1994-11-02 Pfizer Ltd Therapeutic agents
GB9419318D0 (en) 1994-09-24 1994-11-09 Pfizer Ltd Therapeutic agents
DK0812320T3 (da) 1995-02-22 2003-04-14 Aventis Pharma Ltd Amorft piretanid, polymorfe former deraf, fremgangsmåde til fremstilling deraf og deres anvendelse
EP0918758B1 (de) * 1996-07-11 2002-05-02 Novartis AG Verfahren zur herstellung von 1-substituierten 4-cyan-1,2,3-triazolen
TW526195B (en) * 1997-06-10 2003-04-01 Novartis Ag Crystal modifications of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide and their use

Also Published As

Publication number Publication date
PE79799A1 (es) 1999-09-03
AU8437198A (en) 1998-12-30
US20030125568A1 (en) 2003-07-03
EP0994864A1 (de) 2000-04-26
JP2000516258A (ja) 2000-12-05
DE69813560D1 (de) 2003-05-22
RU2194041C2 (ru) 2002-12-10
PL330798A1 (en) 1999-06-07
SK109398A3 (en) 1998-12-02
US20060116520A1 (en) 2006-06-01
WO1998056773A1 (en) 1998-12-17
AR012945A1 (es) 2000-11-22
KR100409168B1 (ko) 2004-01-31
UY25844A1 (es) 2001-08-27
SK109498A3 (en) 1998-12-02
NZ331371A (en) 2000-08-25
TW403740B (en) 2000-09-01
WO1998056772A1 (en) 1998-12-17
HU226107B1 (en) 2008-04-28
DE69811500T2 (de) 2004-04-01
DK0994863T3 (da) 2003-05-26
TW526195B (en) 2003-04-01
HU225153B1 (en) 2006-07-28
AR061004A2 (es) 2008-07-30
ES2192779T3 (es) 2003-10-16
AR012946A1 (es) 2000-11-22
ZA984967B (en) 1999-01-11
CA2614926C (en) 2010-02-09
ATE232852T1 (de) 2003-03-15
KR19990087835A (ko) 1999-12-27
NL300284I1 (nl) 2007-10-01
NO983667D0 (no) 1998-08-11
US8076362B2 (en) 2011-12-13
DK0994864T3 (da) 2003-07-21
IL125732A0 (en) 1999-04-11
CY2007014I1 (el) 2009-11-04
US20100310655A1 (en) 2010-12-09
KR100425656B1 (ko) 2004-05-17
HUP0000798A3 (en) 2000-10-30
CZ292481B6 (cs) 2003-09-17
NZ331370A (en) 2000-08-25
CY2007014I2 (el) 2009-11-04
SI0994864T1 (en) 2003-10-31
IL125733A0 (en) 1999-04-11
CA2614926A1 (en) 1998-12-17
DE69811500D1 (de) 2003-03-27
SI0994863T1 (en) 2003-08-31
NO329314B1 (no) 2010-09-27
CZ253398A3 (cs) 1999-04-14
LU91345I9 (de) 2018-12-31
FR07C0037I1 (de) 2007-08-17
PL330764A1 (en) 1999-05-24
SK283734B6 (sk) 2003-12-02
EP0994864B1 (de) 2003-04-16
KR19990087836A (ko) 1999-12-27
CA2256013C (en) 2007-10-16
US20040167186A1 (en) 2004-08-26
PT994864E (pt) 2003-07-31
US6455556B2 (en) 2002-09-24
JP3672574B2 (ja) 2005-07-20
BR9804947A (pt) 1999-08-24
NO983666D0 (no) 1998-08-11
TR199801631T1 (xx) 1999-06-21
AU8437298A (en) 1998-12-30
NL300284I2 (nl) 2007-11-01
LU91345I2 (fr) 2007-09-04
CZ253498A3 (cs) 1999-04-14
ID21014A (id) 1999-04-08
AU725528B2 (en) 2000-10-12
NO329315B1 (no) 2010-09-27
CZ292260B6 (cs) 2003-08-13
ES2197485T3 (es) 2004-01-01
HK1028031A1 (en) 2001-02-02
AU725517B2 (en) 2000-10-12
US20010037029A1 (en) 2001-11-01
NO983667L (no) 1998-12-17
MY120156A (en) 2005-09-30
BR9804946A (pt) 1999-08-24
IL125733A (en) 2002-12-01
JP2000516259A (ja) 2000-12-05
US7750028B2 (en) 2010-07-06
JP3672575B2 (ja) 2005-07-20
HK1028241A1 (en) 2001-02-09
PL192114B1 (pl) 2006-08-31
CA2256013A1 (en) 1998-12-17
IL125732A (en) 2002-12-01
ID27660A (id) 2001-04-19
ATE237599T1 (de) 2003-05-15
CA2256015A1 (en) 1998-12-17
CA2256015C (en) 2008-06-03
AR061005A2 (es) 2008-07-30
HUP0002113A3 (en) 2002-09-30
CN1217716A (zh) 1999-05-26
DE69813560T2 (de) 2004-02-05
CN1572789A (zh) 2005-02-02
CN1132820C (zh) 2003-12-31
HUP0000798A2 (hu) 2000-10-30
RU2198167C2 (ru) 2003-02-10
DE122007000051I1 (de) 2007-11-08
TR199801630T1 (xx) 1999-06-21
PL191943B1 (pl) 2006-07-31
CO4940452A1 (es) 2000-07-24
FR07C0037I2 (de) 2008-05-16
MY125854A (en) 2006-08-30
PE80999A1 (es) 1999-09-06
EP0994863A1 (de) 2000-04-26
CN1159300C (zh) 2004-07-28
NO983666L (no) 1998-12-17
US6740669B1 (en) 2004-05-25
HK1028242A1 (en) 2001-02-09
CN1298708C (zh) 2007-02-07
CO4940448A1 (es) 2000-07-24
SK283685B6 (sk) 2003-12-02
EP0994863B1 (de) 2003-02-19
HUP0002113A2 (hu) 2001-02-28
ZA984966B (en) 1999-01-11
CN1259127A (zh) 2000-07-05

Similar Documents

Publication Publication Date Title
ATE331719T1 (de) Verwendung von kristallformen von 2- methylthienobenzodiazepinen
ATE202347T1 (de) Aminothiophencarbonsäureamide und ihre verwendung als phosphodiesterase inhibitoren
ATE248150T1 (de) Lactam-enthaltende hydroxamsäure-derivate, deren herstellung und deren verwendung als inhibitoren von matrix-metalloproteasen
DE59712887D1 (de) Substituierte phenylketoenole und ihre verwendung als schädlingsbekämpfungsmittel
DE69332898D1 (de) 4-Carboxamidopiperidinderivate und ihre Verwendung als Neurokinin Antagonisten
DE122007000051I2 (de) Kristallmodifikation von 1-(2,6-difluorbenzyl) -1h-1,2,3-triazol-4-carbonsäureamid und seine verwendung als antiepileptikum
DE59608154D1 (de) Verwendung von polyasparaginsäureamiden als lederhilfsmittel
DE69628195D1 (de) Verwendung von xyloglucanendotransglycosylase
ATE232207T1 (de) N-triazolyl-2-indolcarbonsäureamide und ihre verwendung als cck-a agonisten
ATE181071T1 (de) Piperidinessigsäurederivate und ihre verwendung als fibrinogenantagonistmittel
DE69531048D1 (de) Verwendung von steroidsulphatase-hemmern
ATE229034T1 (de) 3-mercaptoacetylamino-1,5-substituierte-2-oxo- azepan derivate und deren verwendung als inhibitoren von matrix-metalloproteinasen
DE69616944D1 (de) Verwendung von des-aspartat-angiotensin i als wirkstoff gegen herzhypertrophie
DE69333264D1 (de) 3-Phenyl-5-pyridyl-Triazole und ihre Verwendung als Insektizide
DE69811018T2 (de) Triazol-Derivate und ihre Verwendung als antimykotische Mittel
DE59508900D1 (de) Verwendung von Dibrom-thiophen-carbonsäure-Derivaten als Mikrobizide
DE59407240D1 (de) Substituierte azadioxacycloalkene und ihre verwendung als fungizide
DE59813467D1 (de) Verwendung von aerogelen als adsorptionsmittel
DE59605796D1 (de) Oximether- und acrylsäurederivate und ihre verwendung als fungizide
DE69418001D1 (de) Hydrazin-Derivate und ihre Verwendung als Insektizide
DE59510203D1 (de) Aminosäure-Derivate und ihre Verwendung als Schädlingsbekämpfungsmittel
DE59610382D1 (de) Halogenbenzimidazole und ihre verwendung als mikrobizide
DE69505124D1 (de) Verwendung von dibutylmalat als insektenlockstoff
DE69718850T2 (de) Heterocyclische N-Acetonylbenzamide und ihre Verwendung als Fungizide
DE59308823D1 (de) Verwendung von Thioalkandionen als Aromastoffe